The idea behind gene therapy sounds simple – a person is born with a version of a gene that causes a disease, so you deliver a new gene to resolve the(...)

The new blindness treatment has kick-started a debate about the cost of pioneering drugs. Photograph: iStock

Spark Therapeutics says it will charge $850,000 (€707,182) for its new gene therapy for blindness, making it the most expensive drug on the market and(...)

A globally recognised centre of excellence in medical technology, or medtech, Ireland is home to more than 300 companies, employing 25,000 people. (...)

Prof Jane Farrar from Trinity College Dublin: she and Prof Peter Humphries and  Dr Paul Kenna  have spent over 20 years looking at the form of inherited blindness known as retinitis pigmentosa. Photograph: Aidan Crawley

US biopharma group Spark Therapeutics has acquired Dublin-based gene therapy business Genable Technologies in a deal worth more than $15 million (€13.(...)

Genable Technologies founder and director Prof Jane Farrar. Photo: Aidan Crawley

Genable Technologies, a Dublin company targeting genetic diseases causing blindness, has announced a collaboration with US biopharma group Spar(...)